| abstract |
The present invention relates to the use of active substances with virulicidal activitynor a bactericidal effect selectednper file: antiseptics, beta-lactam derivatives,naminoflycocides, tetracycline and itsnderivatives and other substances, for unit productionndoses of the therapeutic agent for the treatment of diseasesnviral or bacterial origin in mammalsnincluding humans, where the number of molecules is effectiventhe substance in the manufactured therapeutic preparationnnumber of infectious units per ml of mammalian bloodnincluding human is equal to 1: 1 -3 x 10 9 for virulencena substance or 1; 1-8 x 1011 for bactericidalnsubstances. |